Therapeutic Targets For Non-Hodgkin Lymphoma - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title Therapeutic Targets For Non-Hodgkin Lymphoma, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : Therapeutic Targets For Non-Hodgkin Lymphoma
link : Therapeutic Targets For Non-Hodgkin Lymphoma

Therapeutic Targets For Non-Hodgkin Lymphoma

By Nephron - Own work, CC BY-SA 3.0, http://ift.tt/2CDRhLz

Here is a study looking at deregulated signaling pathways in non-Hodgkin lymphoma patients, with the objective of finding target proteins for therapeutics.  Some targets were identified, and these can serve as targets of future studies to identify therapeutic approaches.  Thus again shows the link between basic science and human disease treatment. Abstract:

Autoantibody profiling with a systems medicine approach can help identify critical dysregulated signaling pathways (SPs) in cancers. In this way, immunoglobulins G (IgG) purified from the serum samples of 92 healthy controls, 10 pre-treated (PR) non-Hodgkin lymphoma (NHL) patients, and 20 NHL patients who underwent chemotherapy (PS) were screened with a phage-displayed random peptide library. Protein-protein interaction networks of the PR and PS groups were analyzed and visualized by Gephi. The results indicated AXIN2, SENP2, TOP2A, FZD6, NLK, HDAC2, HDAC1, and EHMT2, in addition to CAMK2A, PLCG1, PLCG2, GRM5, GRIN2B, GRIN2D, CACNA2D3, and SPTAN1 as hubs in 11 and 7 modules of PR and PS networks, respectively. PR- and PS-specific hubs were evaluated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. The PR-specific hubs were involved in Wnt SP, signaling by Notch1 in cancer, telomere maintenance, and transcriptional misregulation. In contrast, glutamate receptor SP, Fc receptor-related pathways, growth factors-related SPs, and Wnt SP were statistically significant enriched pathways, based on the pathway analysis of PS hubs. The results revealed that the most PR-specific proteins were associated with events involved in tumor development, while chemotherapy in the PS group was associated with side effects of drugs and/or cancer recurrence. As the findings demonstrated, PR- and PS-specific proteins in this study can be promising therapeutic targets in future studies.

Thus Article Therapeutic Targets For Non-Hodgkin Lymphoma

That's an article Therapeutic Targets For Non-Hodgkin Lymphoma This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Therapeutic Targets For Non-Hodgkin Lymphoma with the link address https://letslifes.blogspot.com/2017/12/therapeutic-targets-for-non-hodgkin.html

Tweet

Subscribe to receive free email updates: